Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Provectus initiates phase I trial in breast cancer
The trial is designed to evaluate the safety and preliminary efficacy of Provecta in five patients with recurrent breast carcinoma. Each patient enrolled in the study is having
The trial is designed to evaluate the safety and preliminary efficacy of Provecta in five patients with recurrent breast carcinoma. Each patient enrolled in the study is having
The three patients in the multiple sclerosis (MS) trial developed severe idiopathic thrombocytopenic purpura (ITP). One of these individuals died from an intracranial hemorrhage, and dosing with Campath
Akathisia, or quivering of the muscles, is a debilitating side effect often experienced by patients with schizophrenia who are prescribed such antipsychotics. This study is one of two
Under the terms of the agreement, 4AZA will grant to Gilead an exclusive, worldwide license for the research, development and commercialization of certain novel compounds for the potential
Conor received conditional investigational device exemption approval from the FDA to begin the trial in a limited number of sites in March 2005. The first patient was enrolled
This acceptance, which caused the company’s shares to jump by almost 10%, confirms that the application was sufficiently complete to allow a substantive review by the FDA. The
Par is the first generic company to receive a tentative approval for the cabergoline tablets and expects to launch the product following expiration of Pfizer’s US patent on
Using a sophisticated brain imaging technique called diffusion tensor imaging (DTI), researchers studied the brains of different groups of adolescents. They compared healthy, non-drug users with heavy marijuana
The treatment is a humanized monoclonal antibody that specifically binds CCR5, a receptor that serves as a portal of entry for HIV into cells of the immune system.
Using functional magnetic resonance imaging (fMRI) the researchers studied the effects of caffeine consumption on brain activation in a network of modules subserving the short-term memory of 15